Those AhR ligands which possess a greater affinity for the receptor are often deemed more toxic; however, researchers have been searching for additional, less toxic AhR ligands that possess immunomodulatory and anti-cancer properties [10,21]. The gene discussed is AHR; the disease is cancer.